6,632
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Insight into the bronchodilator activity of Vitex negundo

, &
Pages 340-344 | Received 05 Nov 2013, Accepted 23 Apr 2014, Published online: 26 Jan 2015

Figures & data

Figure 1. Dose-dependent effects of (A) Vitex negundo crude extract (Vn.Cr) and (B) aminophylline on the carbachol (CCh)-mediated bronchoconstriction in anaesthetized rats. Values shown are mean ± SEM, n = 4, *p < 0.05, **p < 0.01, ***p < 0.001 versus carbachol (ANOVA followed by Dennett's test).

Figure 1. Dose-dependent effects of (A) Vitex negundo crude extract (Vn.Cr) and (B) aminophylline on the carbachol (CCh)-mediated bronchoconstriction in anaesthetized rats. Values shown are mean ± SEM, n = 4, *p < 0.05, **p < 0.01, ***p < 0.001 versus carbachol (ANOVA followed by Dennett's test).

Figure 2. Concentration–response curves showing comparison of (A) Vitex negundo crude extract (Vn.Cr), (B) papaverine, and (C) diltiazem against carbachol (CCh) and K+-induced contractions in isolated guinea-pig tracheal preparations. (D), (E), and (F) show inhibitory concentration–response curves of isoprenaline against carbachol (CCh)-induced contractions in the absence and presence of different concentrations of Vitex negundo extract (Vn.Cr), papaverine, and diltiazem in isolated guinea-pig tracheal preparations. Values shown are mean ± SEM, n = 4–5.

Figure 2. Concentration–response curves showing comparison of (A) Vitex negundo crude extract (Vn.Cr), (B) papaverine, and (C) diltiazem against carbachol (CCh) and K+-induced contractions in isolated guinea-pig tracheal preparations. (D), (E), and (F) show inhibitory concentration–response curves of isoprenaline against carbachol (CCh)-induced contractions in the absence and presence of different concentrations of Vitex negundo extract (Vn.Cr), papaverine, and diltiazem in isolated guinea-pig tracheal preparations. Values shown are mean ± SEM, n = 4–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.